Use of Sotrovimab in a Pregnant Patient With COVID-19 Infection

For individuals with mild-to-moderate coronavirus disease 2019 (COVID-19, caused by severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]), monoclonal antibodies (MOABs) are known to prevent progression of the disease and hospitalization. Pregnant women, who are at an increased risk of severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Isha, Arguello Perez, Esther S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Obstetrics/Gynecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963925/
https://www.ncbi.nlm.nih.gov/pubmed/35371772
http://dx.doi.org/10.7759/cureus.22658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963925/
https://www.ncbi.nlm.nih.gov/pubmed/35371772
http://dx.doi.org/10.7759/cureus.22658

Ejemplares similares